Regardless of the exact mechanism by which AR/p52-02 interferes, the reduction of pARser81 nuclear translocation and decreased stability of AR caused by the inhibitor likely were major factors in the decrease in AR transcriptional activity and associated inhibition of growth of the prostate cancer cells under the androgen deprived condition. Here, AR is linked to prostate cancer.